Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002362022 | SCV002658225 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-12-28 | criteria provided, single submitter | clinical testing | The c.1224delT pathogenic mutation, located in coding exon 11 of the TSC2 gene, results from a deletion of one nucleotide at nucleotide position 1224, causing a translational frameshift with a predicted alternate stop codon (p.F408Lfs*17). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Institute of Medical Genetics and Applied Genomics, |
RCV003776272 | SCV004697349 | pathogenic | Tuberous sclerosis syndrome | 2024-02-21 | criteria provided, single submitter | clinical testing |